These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17152116)

  • 1. Nuchal translucency screening: how do women actually utilize the results?
    Caughey AB; Musci TJ; Belluomini J; Main D; Otto C; Goldberg J
    Prenat Diagn; 2007 Feb; 27(2):119-23. PubMed ID: 17152116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuchal translucency audit: low uptake of invasive testing in screen positive cases.
    Kennelly M; Carroll S; Parland PM
    Ir Med J; 2004; 97(10):304-5. PubMed ID: 15696876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
    Nicolaides KH; Chervenak FA; McCullough LB; Avgidou K; Papageorghiou A
    Am J Obstet Gynecol; 2005 Aug; 193(2):322-6. PubMed ID: 16098850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
    Comstock CH; Malone FD; Ball RH; Nyberg DA; Saade GR; Berkowitz RL; Ferreira J; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
    Am J Obstet Gynecol; 2006 Sep; 195(3):843-7. PubMed ID: 16949423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women.
    Pihl K; Sørensen TL; Nørgaard-Pedersen B; Larsen SO; Nguyen TH; Krebs L; Larsen T; Christiansen M
    Prenat Diagn; 2008 Mar; 28(3):247-53. PubMed ID: 18302310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    Chasen ST; McCullough LB; Chervenak FA
    Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
    Müller MA; Bleker OP; Bonsel GJ; Bilardo CM
    Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal chromosomal abnormalities: antenatal screening and diagnosis.
    Anderson CL; Brown CE
    Am Fam Physician; 2009 Jan; 79(2):117-23. PubMed ID: 19178062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are age cutoffs still used to identify candidates for invasive testing for chromosomal abnormalities?
    Wasden SW; Adams BN; Chasen ST
    J Reprod Med; 2011; 56(3-4):113-6. PubMed ID: 21542527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the utilization of prenatal diagnosis.
    Benn PA; Egan JF; Fang M; Smith-Bindman R
    Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP; Huttly WJ; Wald NJ
    J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
    Valinen Y; Rapakko K; Kokkonen H; Laitinen P; Tekay A; Ahola T; Ryynanen M
    Am J Obstet Gynecol; 2007 Mar; 196(3):278.e1-5. PubMed ID: 17346554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.